Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia-Reference-Cited by-同舟云学术

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia

Published:1992-08 Issue:4 Volume:81 Page:516-519
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Wandl Ursula B.,Kloke Otto,Nagel-Hiemke Marianne,Moritz Thomas,Becher Reinhard,Opalka Bertram,Holtkamp Wilhelm,Bartels Heinrich,Seeber Siegfried,Niederle Norbert

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1992.tb02984.x/fullpdf

Reference19 articles.

1. Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration

2. Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM)

3. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia;Leukemia;2016-03-08

2. Sarcoidosis Induced by Interferon-α in Melanoma Patients;Journal of Immunotherapy;2010-10

3. Safety, Tolerability, and Immunogenicity of Interferons;Pharmaceuticals;2010-04-20

4. Type I IFNs and their role in the development of autoimmune diseases;Expert Opinion on Drug Safety;2009-06-24

5. Pulmonary Complications of Novel Antineoplastic Agents for Hematologic Malignancies;Clinical Pulmonary Medicine;2008-03